Last reviewed · How we verify
NCT03778892: YouthPrEP
Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thailand
NA trial testing 'Project Raincoat' Mobile Phone Application in Adherence, Medication in 200 participants. Completed in 15 December 2019.
15 December 2019
Quick facts
| Lead sponsor | Chulalongkorn University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 1 March 2018 |
| Primary completion | 15 December 2019 |
| Estimated completion | 15 December 2019 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- 'Project Raincoat' Mobile Phone Application
Conditions studied
- Adherence, Medication — all drugs for Adherence, Medication →
- Adolescent Behavior — all drugs for Adolescent Behavior →
- HIV Prevention — all drugs for HIV Prevention →
- Sexual Health — all drugs for Sexual Health →
Sponsor
Chulalongkorn University
Who can join
Adults 15 to 19, male only, with Adherence, Medication or Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, et al · · 2020 · cited 40× · PMID 32869511 · DOI 10.1002/jia2.25564 -
A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, et al · · 2022 · cited 19× · PMID 35451976 · DOI 10.2196/25561
Verify or expand the search:
- PubMed search for NCT03778892
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT06056037 — Making ART Work Among Brazilian Youth · NA · recruiting
- NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction · active not recruiting
- NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth · NA · active not recruiting
Other Chulalongkorn University trials
Trials by the same sponsor.
- NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
- NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
- NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
- NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
- NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03778892 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
- Last refreshed: 23 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778892.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing